| 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the … N Galič, M Humbert, JL Vachiery, S Gibbs, I Lang, A Torbicki, ... European heart journal 37 (1), 67-119, 2016 | 17381* | 2016 |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the … SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ... European heart journal 41 (4), 543-603, 2020 | 9783* | 2020 |
| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European heart journal 39 (3), 213-260, 2018 | 3903* | 2018 |
| Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of … Authors/Task Force Members, A Torbicki, A Perrier, S Konstantinides, ... European heart journal 29 (18), 2276-2315, 2008 | 3836 | 2008 |
| Bosentan therapy for pulmonary arterial hypertension LJ Rubin, DB Badesch, RJ Barst, N Galie, CM Black, A Keogh, T Pulido, ... New England Journal of Medicine 346 (12), 896-903, 2002 | 3738 | 2002 |
| Sildenafil citrate therapy for pulmonary arterial hypertension N Galič, HA Ghofrani, A Torbicki, RJ Barst, LJ Rubin, D Badesch, ... New England Journal of Medicine 353 (20), 2148-2157, 2005 | 3355 | 2005 |
| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 3303 | 2022 |
| Clinical classification of pulmonary hypertension G Simonneau, N Galič, LJ Rubin, D Langleben, W Seeger, ... Journal of the American College of Cardiology 43 (12S), S5-S12, 2004 | 2828 | 2004 |
| Tadalafil therapy for pulmonary arterial hypertension N Galič, BH Brundage, HA Ghofrani, RJ Oudiz, G Simonneau, Z Safdar, ... Circulation 119 (22), 2894-2903, 2009 | 2768* | 2009 |
| ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart Disease of the European … Endorsed by the Association for European Paediatric Cardiology (AEPC), ... European heart journal 31 (23), 2915-2957, 2010 | 2750 | 2010 |
| Inhaled iloprost for severe pulmonary hypertension H Olschewski, G Simonneau, N Galič, T Higenbottam, R Naeije, LJ Rubin, ... New England Journal of Medicine 347 (5), 322-329, 2002 | 2461 | 2002 |
| Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial G Simonneau, RJ Barst, N Galie, R Naeije, S Rich, RC Bourge, A Keogh, ... American journal of respiratory and critical care medicine 165 (6), 800-804, 2002 | 1909 | 2002 |
| Fibrinolysis for patients with intermediate-risk pulmonary embolism G Meyer, E Vicaut, T Danays, G Agnelli, C Becattini, J Beyer-Westendorf, ... New England Journal of Medicine 370 (15), 1402-1411, 2014 | 1896 | 2014 |
| Macitentan and morbidity and mortality in pulmonary arterial hypertension T Pulido, I Adzerikho, RN Channick, M Delcroix, N Galič, HA Ghofrani, ... New England Journal of Medicine 369 (9), 809-818, 2013 | 1704 | 2013 |
| Riociguat for the treatment of pulmonary arterial hypertension HA Ghofrani, N Galič, F Grimminger, E Grünig, M Humbert, ZC Jing, ... New England Journal of Medicine 369 (4), 330-340, 2013 | 1631 | 2013 |
| Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial N Galič, LJ Rubin, MM Hoeper, P Jansa, H Al-Hiti, GMB Meyer, E Chiossi, ... The Lancet 371 (9630), 2093-2100, 2008 | 1327 | 2008 |
| Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension N Galič, JA Barberą, AE Frost, HA Ghofrani, MM Hoeper, VV McLaughlin, ... New England Journal of Medicine 373 (9), 834-844, 2015 | 1269 | 2015 |
| Selexipag for the treatment of pulmonary arterial hypertension O Sitbon, R Channick, KM Chin, A Frey, S Gaine, N Galič, HA Ghofrani, ... New England Journal of Medicine 373 (26), 2522-2533, 2015 | 1131 | 2015 |
| Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era S De Rosa, C Spaccarotella, C Basso, MP Calabrņ, A Curcio, PP Filardi, ... European heart journal 41 (22), 2083-2088, 2020 | 1063 | 2020 |
| Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure KR Stenmark, B Meyrick, N Galie, WJ Mooi, IF McMurtry American Journal of Physiology-Lung Cellular and Molecular Physiology 297 (6 …, 2009 | 994 | 2009 |
